Titan Pharmaceuticals, Inc.

NASDAQ: TTNP    
Share price (4/26/24): $7.09    
Market cap (4/26/24): $6.482 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K/A 12 pages Titan Pharmaceuticals, Inc. Certificate of Designations, Preferences, Rights and Limitations of Series Aa Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-4.1
from 8-K 12 pages Titan Pharmaceuticals, Inc. Certificate of Designations, Preferences, Rights and Limitations of Series Aa Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-4.3
from 8-K 18 pages Common Stock Purchase Warrant Titan Pharmaceuticals, Inc
12/34/56
EX-4.2
from 8-K 19 pages Pre- Funded Common Stock Purchase Warrant Titan Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 17 pages Pre- Funded Common Stock Purchase Warrant Titan Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Titan Pharmaceuticals, Inc
12/34/56
EX-4.11
from S-1/A 4 pages Lock-Up and Voting Agreement
12/34/56
EX-4.10
from S-1/A 31 pages Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of , 2020 Warrant Agency Agreement
12/34/56
EX-4.11
from S-1/A 4 pages Lock-Up and Voting Agreement
12/34/56
EX-4.10
from S-1/A 32 pages Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of , 2020 Warrant Agency Agreement
12/34/56
EX-4.10
from S-1 33 pages Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of , 2020 Warrant Agency Agreement
12/34/56
EX-4.13
from 10-K 2 pages Description of the Registrant’s Common Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.12
from 10-K 4 pages Warrant Amendment Agreement
12/34/56
EX-4.1
from 8-K 20 pages Common Stock Purchase Warrant Titan Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 38 pages Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Class B Warrant Agency Agreement Dated as of October 16, 2019 Class B Warrant Agency Agreement
12/34/56
EX-4.12
from S-1/A 33 pages Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Class C Warrant Agency Agreement Dated as of , 2019 Class C Warrant Agency Agreement
12/34/56
EX-4.11
from S-1/A 32 pages Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Class B Warrant Agency Agreement Dated as of , 2019 Class B Warrant Agency Agreement
12/34/56
EX-4.11
from S-1 36 pages Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of , 2019 Warrant Agency Agreement
12/34/56
EX-4.10
from S-1 21 pages Pre-Funded Common Stock Purchase Warrant Titan Pharmaceuticals, Inc
12/34/56
EX-4.2
from 8-K 17 pages Common Stock Purchase Warrant Titan Pharmaceuticals, Inc
12/34/56